AbbVie · 9 hours ago
Analyst, Finance
Irvine, CA
Full-time
Onsite
Entry Level
$64K/yr - $122K/yr
2+ years expAbbVie is a company dedicated to delivering innovative medicines and solutions for serious health issues. The Financial Analyst role focuses on financial forecasting, planning, and developing financial models to assist in decision-making processes related to various business issues.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Assists with the month end close and financial reporting activities including monthly business/budget reviews, LBEs and preparation of related review packages with variance analysis/commentary on expenses, headcount and capital
Assists with variance analysis and commentary for planning cycles and management reporting under direct guidance of Manager
Provides accurate and timely financial planning and analysis deliverables to direct Manager
Assists with financial support to functional business managers
Supports Accounting Shared Service monthly close and financial reporting processes by reviewing results for completeness and providing variance commentary, which may include P & L, headcount and balance sheet components
Qualification
Required
Bachelor's degree in Finance or Accounting
2+ years of relevant experience in Finance or Accounting
Strong communication skills and customer support
Proficient Excel skills
Preferred
Experience with TM1
Experience with SAP
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-23
2026-01-20
2026-01-20
Company data provided by crunchbase